Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial

• Main Authors: Garyfallia Poulakou (Author), Maxime Barakat (Author), Robert J. Israel (Author), Marcelo R. Bacci (Author), Virazole Collaborator Group for COVID‐19 Respiratory Distress (Author)
• Format: Book
• Published: Wiley, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with demonstrated in vitro activity against multiple viruses, including severe acute respiratory syndrome coronavirus 2 (SARS‐C...